Medical Condition News

RSS

Fight 2 Win PSA launched to find a cure for Hodgkin's Disease

Leading post-production house Optimus Santa Monica today announced that the “Fight 2 Win” PSA – created by Draftfcb Irvine Creative Director Scott Murray, produced by Draftfcb Irvine Senior Producer Tom Anderson, directed by RSA’s Russo Brothers and edited by Optimus Santa Monica Editor Hovig Menakian– has launched and will run through the end of 2009 on Fox, Turner and ESPN.

2 Dec 2009

Results from ongoing clinical trial of ISF35 to be presented at ASH annual meeting

Memgen announced today that results from its ongoing, Leukemia & Lymphoma Society co-sponsored clinical trial in chronic lymphocytic leukemia (CLL) have been selected for an oral presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.

2 Dec 2009

Survey and existing research reveal differences in pain management between genders

For many Canadians, December is the start of the holiday season and a time of joy and celebration, but for some, it can also be a time of increased aches and pains. Whether it's a backache from shoveling away the first snowfall, hanging holiday lights or a headache from the stress of holiday shopping, December brings a new set of aches and pains.

2 Dec 2009

Percutaneous disc decompression keeps patients pain-free up to two years later, shows study

A randomized, controlled study comparing standard conservative therapy to a minimally invasive treatment called percutaneous disc decompression for painful herniated disc revealed that while both treatments help patients in the short run, only disc decompression kept patients pain free up to two years later.

2 Dec 2009

Targeted breast ultrasound: A safe and cost effective alternative for women under 40

Targeted breast ultrasound of suspicious areas of the breast, including lumps, is a safe, reliable and cost-effective alternative to invasive biopsies for women under age 40, according to the findings of two studies presented today at the annual meeting of the Radiological Society of North America (RSNA).

2 Dec 2009

Study identifies genetic link between vitamin D and heart disease

Previous studies have shown a link between low vitamin D status and heart disease. Now a new study shows that patients with high blood pressure who possess a gene variant that affects an enzyme critical to normal vitamin D activation are twice as likely as those without the variant to have congestive heart failure.

2 Dec 2009

Canadians with hemophilia A can use new treatment option, XYNTHA

Canadians with hemophilia A - a rare, inherited blood-clotting disorder - now have a new treatment option with the introduction of XYNTHA(TM), a recombinant factor VIII product for both the control and prevention of bleeding episodes and surgical prophylaxis.

2 Dec 2009

Annual screening ultrasound may benefit women who are at elevated risk for breast cancer

Results of a large-scale clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) provide the first strong evidence of the benefit of annual screening ultrasound for women with dense breasts who are at elevated risk for breast cancer. In addition, the study confirmed that MRI is highly sensitive in depicting early breast cancer.

2 Dec 2009

Antipsychotic medications increase the levels of inflammation markers, find researchers

Overall, antipsychotic medications are reasonably effective, and fairly well tolerated treatments for mood and psychotic disorders. However, treatment with a number of antipsychotic medications is associated with weight gain, and for some, hyperglycemia and hyperlipidemia.

2 Dec 2009

Interactive website to support cancer patients

Millennium: The Takeda Oncology Company today announced the launch of an interactive website in support of the Company’s award-winning global initiative to support patients with cancer.

2 Dec 2009

ZEGERID OTC, a proton pump inhibitor receives FDA approval

Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn.

2 Dec 2009

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Dyax Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.

2 Dec 2009

Middle-aged women more likely to show signs of obesity

A small study of middle-aged women finds that "guilt-ridden dieters," impulsive eaters and those too busy to focus on food are the most likely to show signs of obesity.

2 Dec 2009

Obesity research may be misrepresented by scientists working on bias topics, says UAB study

A new study by researchers at the University of Alabama at Birmingham (UAB) School of Public Health shows that obesity research may be misrepresented by scientists operating with particular biases on topics related to weight, nutrition and the food industry.

1 Dec 2009

CRO to run CEL-SCI's upcoming Phase III clinical trial

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.

1 Dec 2009

Bonn scientists discover a promising new approach to combat obesity

Brown adipose tissue is different from white fat pads. It contains loads of mitochondria, miniature power stations which among other things can 'burn' fat. In doing this, they normally generate a voltage similar to that of a battery, which then provides energy for cellular processes.

1 Dec 2009

ASH to host annual High School Student Symposium at New Orleans Marriott

The American Society of Hematology (ASH) will host its annual High School Student Symposium at the New Orleans Marriott on Thursday, December 3, at 8:00 a.m. CST.

1 Dec 2009

Acceleron Pharma announces study results of its ACE-011 and ACE-536 blood forming agents

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

1 Dec 2009

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

1 Dec 2009

Calistoga Pharmaceuticals to present data on its CAL-101 inhibitor at the 51st ASH meeting

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that clinical and preclinical data supporting the role of CAL-101, an oral, p110δ(delta) selective PI3K inhibitor in patients with hematologic malignancies, will be featured in two oral presentations at the upcoming 51st American Society of Hematology (ASH) Annual Meeting taking place in New Orleans, LA.

1 Dec 2009

Medical Condition News

Fight 2 Win PSA launched to find a cure for Hodgkin's Disease

Results from ongoing clinical trial of ISF35 to be presented at ASH annual meeting

Survey and existing research reveal differences in pain management between genders

Percutaneous disc decompression keeps patients pain-free up to two years later, shows study

Targeted breast ultrasound: A safe and cost effective alternative for women under 40

Study identifies genetic link between vitamin D and heart disease

Canadians with hemophilia A can use new treatment option, XYNTHA

Annual screening ultrasound may benefit women who are at elevated risk for breast cancer

Antipsychotic medications increase the levels of inflammation markers, find researchers

Interactive website to support cancer patients

ZEGERID OTC, a proton pump inhibitor receives FDA approval

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Middle-aged women more likely to show signs of obesity

Obesity research may be misrepresented by scientists working on bias topics, says UAB study

CRO to run CEL-SCI's upcoming Phase III clinical trial

Bonn scientists discover a promising new approach to combat obesity

ASH to host annual High School Student Symposium at New Orleans Marriott

Acceleron Pharma announces study results of its ACE-011 and ACE-536 blood forming agents

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Calistoga Pharmaceuticals to present data on its CAL-101 inhibitor at the 51st ASH meeting

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News